Jasmin Dhirajlal Monpara

Title: **Innovative Contributions of Jasmin Dhirajlal Monpara in Pharmaceutical Technology**

Introduction

Jasmin Dhirajlal Monpara is an accomplished inventor based in Mumbai, India. With a focus on pharmaceutical technology, she has made significant strides in the development of materials that enhance drug delivery systems. Her work is particularly notable for its impact on sustained-release pharmaceutical formulations.

Latest Patents

Monpara holds a patent for "Polyvinyl alcohol particles, pharmaceutical binder using same, pharmaceutical tablet, sustained-release pharmaceutical tablet, and method for producing polyvinyl alcohol particles." This innovative patent presents polyvinyl alcohol fine particles designed to serve as pharmaceutical binders. The resulting formulations display desirable properties such as good sustained release, high hardness, and excellent friability. The invention specifically emphasizes the inclusion of 25 mol % or more of a gauche structure within the polyvinyl alcohol molecules, located in a 0.8-nm region from the particle surface.

Career Highlights

Jasmin Monpara is associated with The Nippon Synthetic Chemical Industry Co., Ltd., a firm recognized for its advancements in synthetic chemicals and innovative applications. Her technical expertise in polymer chemistry has contributed significantly to the pharmaceutical sector, particularly in optimizing the performance of drug formulations.

Collaborations

Throughout her career, Monpara has collaborated with prominent colleagues, including Chizuko Furo and Taiji Kanda. These collaborations have fostered a productive environment for innovation and development within her field, enabling the team to tackle complex challenges in pharmaceutical formulation.

Conclusion

Jasmin Dhirajlal Monpara exemplifies the spirit of innovation in the pharmaceutical industry. Her patent on polyvinyl alcohol particles not only showcases her ingenuity but also demonstrates the potential for enhancing drug delivery systems. With her continued contributions, the future of pharmaceutical technology looks promising.